LOSI, Lorena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.039
EU - Europa 14.704
AS - Asia 9.130
SA - Sud America 1.214
AF - Africa 170
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 47.281
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.727
IT - Italia 7.213
GB - Regno Unito 3.250
SG - Singapore 3.173
CN - Cina 2.273
HK - Hong Kong 1.024
BR - Brasile 906
VN - Vietnam 892
SE - Svezia 840
DE - Germania 753
BD - Bangladesh 427
FR - Francia 419
FI - Finlandia 412
UA - Ucraina 371
RU - Federazione Russa 367
NL - Olanda 327
TR - Turchia 278
KR - Corea 203
IN - India 201
BG - Bulgaria 154
CA - Canada 150
ID - Indonesia 136
AR - Argentina 117
MX - Messico 92
AL - Albania 80
PL - Polonia 79
ES - Italia 75
IQ - Iraq 73
AE - Emirati Arabi Uniti 68
JP - Giappone 68
ZA - Sudafrica 56
BE - Belgio 49
PK - Pakistan 48
IE - Irlanda 47
RO - Romania 44
LT - Lituania 43
CL - Cile 37
MY - Malesia 37
EC - Ecuador 35
CH - Svizzera 32
CO - Colombia 31
UZ - Uzbekistan 30
PH - Filippine 25
VE - Venezuela 24
MA - Marocco 22
CZ - Repubblica Ceca 20
NP - Nepal 20
PY - Paraguay 19
IL - Israele 18
KE - Kenya 18
JO - Giordania 17
LV - Lettonia 17
SA - Arabia Saudita 16
UY - Uruguay 16
AT - Austria 15
PE - Perù 15
EG - Egitto 14
DK - Danimarca 13
PT - Portogallo 13
TH - Thailandia 13
TN - Tunisia 13
BO - Bolivia 12
DZ - Algeria 12
AU - Australia 11
BY - Bielorussia 11
ET - Etiopia 11
IR - Iran 11
KZ - Kazakistan 11
TW - Taiwan 11
AZ - Azerbaigian 10
CR - Costa Rica 9
GR - Grecia 9
JM - Giamaica 9
GT - Guatemala 8
PS - Palestinian Territory 8
DO - Repubblica Dominicana 7
HU - Ungheria 7
KG - Kirghizistan 7
MD - Moldavia 7
NO - Norvegia 7
SI - Slovenia 7
PA - Panama 6
PR - Porto Rico 6
RS - Serbia 6
BZ - Belize 5
QA - Qatar 5
HN - Honduras 4
LK - Sri Lanka 4
TT - Trinidad e Tobago 4
XK - ???statistics.table.value.countryCode.XK??? 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
CG - Congo 3
EE - Estonia 3
EU - Europa 3
GA - Gabon 3
GE - Georgia 3
LB - Libano 3
MT - Malta 3
Totale 47.224
Salva come PNG Salva come JPEG
Città #
Southend 2.496
Singapore 2.037
Ashburn 1.824
Santa Clara 1.759
Fairfield 1.665
Woodbridge 1.129
Hong Kong 1.009
Chicago 1.005
Chandler 940
Houston 831
San Jose 744
Jacksonville 684
Los Angeles 678
Seattle 666
Wilmington 650
Rome 627
Hefei 601
Cambridge 592
Dearborn 574
Ann Arbor 532
Milan 486
Nyköping 485
Salt Lake City 441
Beijing 432
London 370
Modena 340
New York 308
Council Bluffs 306
Ho Chi Minh City 274
Helsinki 261
Elk Grove Village 215
Tampa 211
Hanoi 208
The Dalles 198
Naples 197
Seoul 192
San Diego 175
Shanghai 162
Dallas 159
Princeton 157
Bologna 156
Izmir 145
Sofia 140
Frankfurt am Main 134
Eugene 130
Sterling 125
Lauterbourg 122
Turin 115
Bari 113
Lancaster 113
Buffalo 111
São Paulo 103
Moscow 102
Florence 97
Jakarta 91
Palermo 86
Munich 83
Bremen 77
Cagliari 70
Columbus 67
Parma 67
Verona 66
Reggio Emilia 65
Tirana 65
Des Moines 64
Detroit 64
Miami 64
Orem 63
Phoenix 62
Dulles 60
Tokyo 59
Boardman 57
Perugia 57
Warsaw 56
Catania 53
Da Nang 53
Redwood City 51
Atlanta 50
Toronto 48
Fremont 47
Denver 46
Dublin 44
Padova 41
Pescara 41
Genoa 40
Chennai 39
Montreal 38
Brussels 37
Brooklyn 35
Stockholm 35
Kansas City 34
Trieste 34
Falls Church 33
Haiphong 33
Pittsburgh 33
Rio de Janeiro 33
Guangzhou 32
Brescia 31
Nanjing 29
Napoli 28
Totale 30.687
Salva come PNG Salva come JPEG
Nome #
Robbins e Cotran Atlante di Anatomia Patologica 6.480
Exome sequencing and bioinformatic approaches reveals rare sequence variants involved in cell signalling and elastic fibre homeostasis: new evidence in the development of ectopic calcification 523
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 458
LonP1 Differently Modulates Mitochondrial Function and Bioenergetics of Primary Versus Metastatic Colon Cancer Cells 451
Wnt pathway, angiogenetic and hormonal markers in sporadic and familial adenomatous polyposis-associated juvenile nasopharyngeal angiofibromas (JNA) 451
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 442
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 438
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-asociated polyposis pedigrees 426
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 420
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 416
Brooke-Spiegler syndrome: Report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes 414
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy 407
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or Keratoacanthomas 407
Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells. 405
DNA methylation profiling of esophageal adenocarcinoma using Methylation Ligation-dependent Macroarray (MLM) 405
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 402
Assessment of K-ras, Smad4 and p53 gene alterations in colorectal metastases and their role in the metastatic process 399
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 393
Repurposing of drugs targeting yap-tead functions 392
K-ras and p53 mutations in human colorectal aberrant crypt foci 390
Microsatellite instability in multiple colorectal tumors 386
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 385
Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions RID B-2583-2012 383
Down-regulation of μ-protocadherin expression is a common event in colorectal carcinogenesis 383
Aetiology of colorectal cancer and relevance of monogenic inheritance. 380
Molecular screening for Hereditary Non Polyposis Colorectal Cancer (HNPCC): a prospective, population-based study 375
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 373
Preoperative Therapy for Lower Rectal Cancer and Modifications in Distance From Anal Sphincter 372
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 369
Malignant melanoma in patients with hereditary nonpolyposis colorectal cancer 368
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 363
Aberrant crypt foci in patients with colorectal cancer 362
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 361
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialized cancer Registry 360
Argyrophilic nucleolar organizer regions and bromodeoxyuridine and h3-thymidine labelling indices in colorectal cancer 359
Biological parameters determining the clinical outcome of autologous cultures of limbal stem cells 359
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 355
Promoter Methylation and Down-regulated Expression of the TBX15 Gene in Ovarian Carcinoma 348
Involvement of epigenetic modification of TERT promoter in response to all-trans retinoic acid in ovarian cancer cell lines 348
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells 348
Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool 347
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 347
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma 344
Prognostic significance of K-ras mutations in colorectal carcinoma. 341
Histology of aberrant crypt foci in the human colon 338
Loss of Smad4 expression predicts liver metastasis in human colorectal cancer 337
Expression of p53 protein in prostate cancers of different histologic types. 336
Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts 334
Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. 333
Distinct DNA Methylation Profiles in Ovarian Tumors: Opportunities for Novel Biomarkers 330
Preclinical study for treatment of hypospadias by advanced therapy medicinal products 326
Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma 325
Biologic characterization of Hereditary Non-Polyposis Colorectal Cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. 323
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 323
Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer 320
Stability of K-ras mutations throughout the natural history of human colorectal cancer. 315
Primary mucinous (so-called colloid) carcinomas of the lung - A clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression 314
Deep learning techniques for detecting preneoplastic and neoplastic lesions in human colorectal histological images 312
Folic Acid-Peptide Conjugates Combine Selective Cancer Cell Internalization with Thymidylate Synthase Dimer Interface Targeting 312
Loss of expression of μ-protocadherin and protocadherin-24 in sporadic and hereditary nonpolyposis colorectal cancers 310
MELANOSIS (PIGMENTED MELANOCYTOSIS) OF THE PROSTATE GLAND. 310
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 308
Paneth and argyrophil cells in prostatic carcinoma. 303
Microsatellite instability and colorectal cancer prognosis. 303
Can immunohistochemistry improve the pathological diagnosis of placenta accreta spectrum (PAS) disorders? 298
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 296
Desmoplastic melanoma: a challenge for the oncologist 295
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 292
Evolution of intratumoral genetic heterogeneity during colorectal cancer progression 290
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 288
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 286
Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer 286
Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells 279
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 278
Leser-Trélat syndrome in patients affected by six multiple metachronous primitive cancers. 277
Colorectal carcinoma in different age groups: A population based investigation 274
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 274
Prognostic value of "Dworak" tumor regression grade (TRG) after pre-operative chemo-radiotherapy in rectal cancer (RC) 273
Regenerative Medicine of Epithelia: Lessons From the Past and Future Goals 272
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 270
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 269
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 269
Malignant peritoneal mesothelioma in a woman with bilateral ovarian serous borderline tumour: Potential interactions between the two diseases 266
SOX2 Is a Univocal Marker for Human Oral Mucosa Epithelium Useful in Post-COMET Patient Characterization 265
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 261
Biological characterization of mucinous carcinoma of the colon and rectum 259
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 258
CDX-2 homeobox gene and MUC2 expression identifies true mucinous (so-called colloid) carcinoma of the lung and justifies its indolent outcome 250
High Expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells 244
Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation. 244
Alternative marker panel for Microsatellite Instability analysis in deection of contitutional MLH1 and MSH2 mutations. 243
TERT promoter methylation and protein expression as predictive biomarkers for recurrence risk in patients with serous borderline ovarian tumours 240
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model 240
Myxoid metastases of melanoma: report of three cases and review of the literature 235
Survival for colon and rectal cancer in a population-based cancer registry 234
Mesalazine inhibits the beta-catenin signalling pathway acting through the upregulation of mu-protocadherin gene in colo-rectal cancer cells 233
Pigment epithelial-derived factor: a new player in dermal elastic fibre calcification? 232
Cadherins down-regulation: towards a better understanding of their relevance in colorectal cancer 232
Evidence for mitochondrial Lonp1 expression in the nucleus 229
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 228
Totale 39.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 174.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 174.945
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021223 0 0 0 0 0 0 0 0 0 0 0 223
2021/20223.358 134 361 305 241 124 176 224 201 359 225 649 359
2022/20233.584 377 366 236 330 371 456 148 356 401 119 215 209
2023/20243.619 187 202 247 363 571 310 287 376 152 288 262 374
2024/20258.195 314 144 308 676 1.443 1.094 640 541 969 413 725 928
2025/202616.120 813 550 917 2.524 4.435 907 1.425 607 1.269 1.120 896 657
Totale 47.518